Loading...
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DNA’s FA Score shows that 1 FA rating(s) are green whileNAUT’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DNA’s TA Score shows that 5 TA indicator(s) are bullish while NAUT’s TA Score has 5 bullish TA indicator(s).
DNA (@Biotechnology) experienced а -6.08% price change this week, while NAUT (@Biotechnology) price change was +7.49% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +3.15%. For the same industry, the average monthly price growth was +4.69%, and the average quarterly price growth was +62.76%.
DNA is expected to report earnings on Aug 13, 2024.
NAUT is expected to report earnings on Jul 31, 2024.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
DNA | NAUT | DNA / NAUT | |
Capitalization | 1.86B | 360M | 515% |
EBITDA | N/A | N/A | - |
Gain YTD | -50.349 | -4.013 | 1,255% |
P/E Ratio | N/A | N/A | - |
Revenue | N/A | N/A | - |
Total Cash | N/A | N/A | - |
Total Debt | 242M | N/A | - |
DNA | NAUT | |
---|---|---|
RSI ODDS (%) | 1 day ago86% | N/A |
Stochastic ODDS (%) | 1 day ago70% | 1 day ago69% |
Momentum ODDS (%) | 1 day ago78% | 1 day ago68% |
MACD ODDS (%) | 1 day ago70% | 1 day ago75% |
TrendWeek ODDS (%) | 1 day ago83% | 1 day ago66% |
TrendMonth ODDS (%) | 1 day ago85% | 1 day ago61% |
Advances ODDS (%) | 3 days ago76% | 1 day ago81% |
Declines ODDS (%) | 1 day ago84% | 4 days ago81% |
BollingerBands ODDS (%) | 4 days ago68% | 1 day ago64% |
Aroon ODDS (%) | 1 day ago87% | 1 day ago77% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRBLX | 60.51 | 0.74 | +1.24% |
Parnassus Core Equity Investor | |||
DSMFX | 13.75 | 0.15 | +1.10% |
Destinations Small-Mid Cap Equity I | |||
BRKCX | 13.77 | 0.10 | +0.73% |
MFS Blended Research Em Mkts Eq C | |||
ISMSX | 10.48 | 0.03 | +0.29% |
VY® American Century Sm-Mid Cp Val S2 | |||
GEMSX | 20.73 | N/A | N/A |
Goldman Sachs Emerging Markets Eq Svc |
A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with ZNTL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then ZNTL could also see price increases.
Ticker / NAME | Correlation To NAUT | 1D Price Change % | ||
---|---|---|---|---|
NAUT | 100% | +0.35% | ||
ZNTL - NAUT | 43% Loosely correlated | +2.61% | ||
AXON - NAUT | 42% Loosely correlated | -0.85% | ||
MIRM - NAUT | 42% Loosely correlated | +0.77% | ||
ARRY - NAUT | 38% Loosely correlated | -3.01% | ||
QSI - NAUT | 38% Loosely correlated | +1.64% | ||
More |